(Q42825110)

8 November 2017

title

SHC and GRB-2 are constitutively by an epidermal growth factor receptor with a point mutation in the transmembrane domain (English)

1 reference

8 November 2017

SHC and GRB-2 Are Constitutively Activated by an Epidermal Growth Factor Receptor with a Point Mutation in the Transmembrane Domain (English)

1 reference

https://api.crossref.org/works/10.1074/JBC.270.33.19557

signal transducing adaptor protein

8 July 2024

main subject

transmembrane protein

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7642641

8 July 2024

M. Miloso

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7642641

8 July 2024

M. Mazzotti

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7642641

8 July 2024

W. C. Vass

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7642641

8 July 2024

L. Beguinot

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7642641

8 July 2024

language of work or name

English

0 references

publication date

1 August 1995

1 reference

8 November 2017

18 August 1995

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7642641

full work available at URL

8 July 2024

http://www.jbc.org/article/S0021925817464246/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7642641

https://api.elsevier.com/content/article/PII:S0021925817464246?httpAccept=text/xml

8 July 2024

1 reference

https://api.crossref.org/works/10.1074/JBC.270.33.19557

https://api.elsevier.com/content/article/PII:S0021925817464246?httpAccept=text/plain

8 July 2024

1 reference

https://api.crossref.org/works/10.1074/JBC.270.33.19557

https://syndication.highwire.org/content/doi/10.1074/jbc.270.33.19557

8 July 2024

1 reference

https://api.crossref.org/works/10.1074/JBC.270.33.19557

Journal of Biological Chemistry

8 July 2024

published in

1 reference

8 November 2017

volume

270

1 reference

8 November 2017

1 reference

8 November 2017

page(s)

19557-19562

1 reference

A new avian erythroblastosis virus, AEV-H, carries erbB gene responsible for the induction of both erythroblastosis and sarcomas

8 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

Activation of the feline c-fms proto-oncogene: multiple alterations are required to generate a fully transformed phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

Signal transduction by receptors with tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate proto-oncogene expression and DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

Ligand-induced stimulation of epidermal growth factor receptor mutants with altered transmembrane regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

Ligand-induced transformation by a noninternalizing epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

DNA sequencing with chain-terminating inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

Functional heterogeneity of proto-oncogene tyrosine kinases: the C terminus of the human epidermal growth factor receptor facilitates cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

Tyrosine phosphorylation and activation of homologous protein kinases during oocyte maturation and mitogenic activation of fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

Structural Requirements of the Epidermal Growth Factor Receptor for Tyrosine Phosphorylation of eps8 and eps15, Substrates Lacking Src SH2 Homology Domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

Regulation of signal transduction and signal diversity by receptor oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.33.19557

Journal of Biological Chemistry

21 January 2018

265

616

Carpenter

1990

1 reference

https://api.crossref.org/works/10.1074/JBC.270.33.19557

SH2 and SH3 domains: from structure to function

8 July 2024

1 reference

https://api.crossref.org/works/10.1074/JBC.270.33.19557

Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C gamma

8 July 2024

1 reference

https://api.crossref.org/works/10.1074/JBC.270.33.19557

Antibodies to the autophosphorylation sites of the epidermal growth factor receptor protein-tyrosine kinase as probes of structure and function.

8 July 2024

1 reference

https://api.crossref.org/works/10.1074/JBC.270.33.19557

Three dimensional structure of the transmembrane region of the proto-oncogenic and oncogenic forms of the neu protein

8 July 2024

1 reference

https://api.crossref.org/works/10.1074/JBC.270.33.19557

8 July 2024

Identifiers

1 reference

8 November 2017

1 reference